Page last updated: 2024-10-27

fluoxetine and Anemia, Aplastic

fluoxetine has been researched along with Anemia, Aplastic in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosch, X1
Vera, M1

Other Studies

1 other study available for fluoxetine and Anemia, Aplastic

ArticleYear
Aplastic anaemia during treatment with fluoxetine.
    Lancet (London, England), 1998, Apr-04, Volume: 351, Issue:9108

    Topics: Adult; Anemia, Aplastic; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotoni

1998